|
Volumn 62, Issue 1, 2012, Pages 1-2
|
Stress, anxiety and depression: Toward new treatment strategies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
KETAMINE;
ANXIETY DISORDER;
BEHAVIOR DISORDER;
COMORBIDITY;
DEPRESSION;
DISEASE ASSOCIATION;
DISEASE PREDISPOSITION;
DISEASE SEVERITY;
DRUG EFFECT;
EDITORIAL;
HUMAN;
MEDICAL RESEARCH;
MENTAL STRESS;
NERVE CELL PLASTICITY;
NEUROBIOLOGY;
PHENOTYPE;
PRIORITY JOURNAL;
PSYCHOSIS;
RISK ASSESSMENT;
RISK FACTOR;
SYMPTOM;
SYMPTOMATOLOGY;
TRANSCRANIAL MAGNETIC STIMULATION;
ANXIETY;
DEPRESSION;
HUMANS;
STRESS, PSYCHOLOGICAL;
|
EID: 80054096914
PISSN: 00283908
EISSN: 18737064
Source Type: Journal
DOI: 10.1016/j.neuropharm.2011.09.023 Document Type: Editorial |
Times cited : (24)
|
References (0)
|